Asia Beat: Foreign distributors eye gold in the dragon's den
This article was originally published in Scrip
Executive Summary
The significance of Cardinal Health's move into China's distribution industry through the acquisition of Zuellig's business in the country should not be underestimated. It could prove nothing less than transformational for the sector as a whole, which continues to be marked by fragmentation and inefficiency.